Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 6,719.0 | $467K | 0.41% | NEW | — | $69.55 | -44.2% |
| 82 | — | MIND MEDICINE MINDMED INC | — | 34,841.0 | $467K | 0.41% | NEW | — | $13.39 | — |
| 83 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 6,689.0 | $444K | 0.39% | NEW | — | $66.39 | +13.8% |
| 84 | ALMS | ALUMIS INC | Healthcare | 43,769.0 | $427K | 0.37% | NEW | — | $9.76 | +127.2% |
| 85 | DYN | DYNE THERAPEUTICS INC | Healthcare | 21,535.0 | $421K | 0.37% | NEW | — | $19.56 | -11.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%